scholarly journals GW29-e1980 A retrospective study on the relationship between contrast volume and myocardial injury during elective percutaneous coronary intervention

2018 ◽  
Vol 72 (16) ◽  
pp. C133
Author(s):  
LuYao Ding ◽  
WenBin Zhang
2018 ◽  
Vol 29 (8) ◽  
pp. 638-646 ◽  
Author(s):  
Francesco Fracassi ◽  
Vincenzo Vetrugno ◽  
Alessandro Mandurino-Mirizzi ◽  
Nicola Cosentino ◽  
Serena Panicale ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-8
Author(s):  
Tadeusz Osadnik ◽  
Andrzej Lekston ◽  
Kamil Bujak ◽  
Joanna Katarzyna Strzelczyk ◽  
Lech Poloński ◽  
...  

Background and Aim. The specific association between genetic variation and in-stent restenosis is still only partly understood. The aim of this study is to analyze the relationship between functional polymorphisms in the genes encoding vascular endothelial growth factor A (VEGF-A; rs699947) and transforming growth factor beta 1 (TGF-β1; rs1800470) and target lesion revascularization (TLR) risk. Methods. A total of 676 patients (805 lesions) with stable coronary artery disease (SCAD) who received elective percutaneous coronary intervention (PCI) with at least one bare-metal stent implantation were included. The primary study endpoint was TLR at a 4-year follow-up. Results. The TLR rate was higher in patients with the VEGFA A/A genotype (15.4%) than in patients with the VEGFA A/C (7.9%) and C/C (8.9%) genotypes (p=0.009). The VEGFA A/A genotype, after adjustment for clinical and procedural covariates, remained significantly and independently associated with the TLR (hazard ratio—2.09 [95% confidence interval 1.32–3.33, p=0.0017]). However, we found no association between TLR and the TGFB1 genotype. Conclusion. The VEGFA A/A genotype is significantly and independently associated with TLR risk in Polish SCAD patients who received elective PCI with bare-metal stent implantation.


2020 ◽  
Vol 132 ◽  
pp. 106704
Author(s):  
Edoardo Bressi ◽  
Fabio Mangiacapra ◽  
Giuseppe Di Gioia ◽  
Mariano Pellicano ◽  
Luigi Di Serafino ◽  
...  

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Nehal Badr Elnahhas ◽  
Khaled El-Menyawi ◽  
Ahmad Elsayed Mostafa ◽  
Mostafa El Nozahi

Abstract Background Regardless of the diabetic status of patients with coronary artery disease, both hyperglycemia and hypoglycemia are adversely associated with cardiovascular events. Numerous studies have concluded that hyperglycemia is common in diabetic and non-diabetic patients with STelevation myocardial infarction (STEMI) and is associated with a higher risk of death and in-hospital complications. Aim and Objectives The aim of this study is to assess the relationship between elevated preprocedural random blood glucose level and peri-procedural myocardial injury in patients undergoing elective percutaneous coronary intervention. Patients and Methods This Cohort study included 110 patients who presented with chronic coronary syndrome to the cardiology department of Ain Shams university hospitals and underwent elective PCI. They were divided into 2 equal groups, 55 as hyperglycemic group and 55 as euglycemic group. Blood glucose level was measured immediately before the procedure. Blood samples for cardiac troponin (I) were obtained before the procedure and 12 hours after the procedure. Results There was statistically significant difference between the two groups regarding incidence of both myocardial infarction and myocardial injury, both being higher among the hyperglycemic group (P-value: 0.022) &(P-value: 0.001) respectively. All five patients who had myocardial infarction belonged to the hyperglycemic group. 23 patients with myocardial injury belonged to the hyperglycemic group while only 7 patients with myocardial injury belonged to the euglycemic group. Conclusion We conclude that abnormally high pre-procedural plasma glucose levels in patients undergoing coronary angioplasty are associated with an increased incidence of peri-procedural myocardial injury and infarction in patients undergoing elective PCI.


Sign in / Sign up

Export Citation Format

Share Document